NASDAQ
Kyverna Therapeutics, Inc. (KYTX) has a current ratio of 7.75x as of Monday, May 25, 2026. This represents a 48.01% increase compared to its 12-month average of 5.24x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.